CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways

In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including:

Rationale for targeting CELMoDs in NHL

Mechanism of action of CELMoDs

Key studies and available efficacy and safety data with investigational CELMoDs in NHL

Key ongoing clinical trials of CELMoDs in NHL

Strategies to boost NHL clinical trial diversity among underserved communities

Presenters:

Julio C. Chavez, MD, MS

Associate Member

Department of Malignant Hematology

ICE-T Clinical Research Medical Director for Hematologic Malignancies

H. Lee Moffitt Cancer…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.